Consistently, combined NSD1 and NSD2 inhibition resulted in significant cytotoxicity in AR-positive PCa cells (Fig. 3n), whereas inactivation of either genes alone had little to no tumor-killing effect in prostatic cell lines (Extended Data Fig. 7j). Here, NSD1 is linked to neoplasm.